Laneka Raison is a Philadelphia, Pennsylvania based nurse practitioner who is specialized as Primary Care nurse. Her current practice location is 700 Spruce St Ste 403, Philadelphia. Patients can reach her at 215-829-8420 or can fax her at 215-829-8418. Laneka Raison is NP with specialization in Primary Care and her NPI number (Unique professional ID assigned by NPPES) is 1194508705. Laneka Raison is educated, certified and licensed to provide comprehensive, chronic, continuous care characterized by a long-term relationship with the patient. Primary Care Nurse Practitioners (PCNPs) screen, diagnose, and treat common acute and chronic medical diseases and conditions. They are also involved in health promotion, screening, and educating about primary prevention.
Complete Profile:
Laneka Raison speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Laneka Raison
Specialization:
Primary Care Nurse Practitioner (PCNP)
Gender:
Female
Credentials:
NP
Practice Address:
700 Spruce St Ste 403, Philadelphia, Pennsylvania, 19106-4027
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1194508705
NPI Enumeration Date:
16 Aug, 2023
NPI Last Update On:
11 Jun, 2024
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Laneka Raison 700 Spruce St, Suite 403 Philadelphia, Pennsylvania
Zip:
19106-4022
Phone Number:
215-829-8420
Fax Number:
215-829-8418
Patients can reach Laneka Raison at 700 Spruce St Ste 403, Philadelphia, Pennsylvania or can call to book an appointment on 215-829-8420.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.